Single-center experience with the combination of Cardioplexol™ cardioplegia and MiECC for isolated coronary artery bypass graft procedures

BACKGROUND: Cardioplexol™ with its low volume (100 mL) was originally conceived as cardioplegic solution for MiECC procedures. Introduced in its current form in 2008 in our clinic, it has immediately demonstrated attractive advantages including the easy and rapid administration by the surgeon him/he...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Thorac Dis
Κύριοι συγγραφείς: Tevaeara Stahel, Hendrik, Barandun, Silvio, Kaufmann, Emilie, Gahl, Brigitta, Englberger, Lars, Jenni, Hansjoerg, Weber, Alberto, Aymard, Thierry, Gygax, Erich, Carrel, Thierry
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: AME Publishing Company 2019
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586578/
https://ncbi.nlm.nih.gov/pubmed/31293796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.04.47
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια